Related by context. All words. (Click for frequent words.) 62 Acetavance TM 61 Ofirmev 60 mesylate tablets approved 59 IV acetaminophen 58 BEMA Granisetron 58 Submits Investigational 58 successfully commercialize Iluvien 58 Announces Tentative Approval 57 Linjeta TM 57 Vertex hepatitis C 56 Biologic License Application BLA 56 5 lipoxygenase inhibitor 56 sNDAs 56 Submits Response 56 Omigard 56 Surfaxin lucinactant 56 CIP TRAMADOL ER 56 balsalazide tablet 56 HEPLISAV ™ 56 Topiramate tablets 56 Risperidone Oral Solution 55 Receives Tentative FDA 55 Q#IR 55 Hematide ™ peginesatide 55 authority Gurian Sherman 55 Enjuvia 55 Entereg alvimopan 54 Proquin 54 granisetron hydrochloride 54 OMAPRO ™ 54 assigned PDUFA 54 BLA filing 54 IONSYS 54 Somatuline R Autogel R 54 Ondansetron Injection 54 donepezil hydrochloride 54 designated Restanza 54 Inc NGSX 54 transmucosal delivery system 54 granted Ortec 53 CONBRIZA 53 UCB Keppra 53 Nabi HB Intravenous 53 BiDil XR 53 vinorelbine tartrate 53 PROVENGE ® 53 Pirespa 53 TBC# 53 docetaxel emulsion 53 pulls Darvon painkiller 53 Marketing Authorisation Application MAA 53 Marketing Approval PMA 53 ANDA submission 53 Pre IND 53 supplemental biologics 53 Troxatyl TM 52 Saforis 52 Allovectin 7 52 rPA anthrax vaccine 52 Entereg TM 52 PANVAC VF 52 Emezine 52 Entocort 52 REMOXY NDA 52 OTC ZEGERID 52 Resubmission 52 Trobalt 52 OTC Zegerid 52 Impax ANDA 52 Biological License Application 52 OLEPTRO 52 Metformin Hydrochloride 52 Tectin 52 Nivestim 52 inhaled AAT 52 NESINA 51 Orathecin 51 Marketing Authorisation Application 51 sNDA filing 51 liver resection surgeries 51 rhLF 51 Zensana 51 Namenda XR 51 Cintredekin besudotox 51 Spiegelmer ® 51 sodium oxybate JZP 51 designated cethromycin 51 Matrixx due diligence 51 Excellagen 51 Decentralized Procedure 51 JZP 6 51 Novartis Galvus 51 initiate Phase IIa 51 CIP Fenofibrate 51 Orphan Status 50 Zidovudine Tablets 50 midstage trials 50 Metformin GR 50 GLP1 agonist 50 Cellegesic 50 oral methylnaltrexone 50 Arzerra TM 50 Phase IIb clinical trials 50 Esbriet pirfenidone 50 Patanase 50 Xifaxan rifaximin 50 Grants Orphan Drug 50 Premarket Approval PMA 50 Irinotecan Hydrochloride Injection 50 Brinavess 50 gepirone ER 50 Targretin capsules 50 CLIRS trial 50 midstage clinical 50 Barr ANDA 50 Stedesa 50 GRALISE 50 Premarket Approval 50 Voraxaze 49 Averion core competencies 49 Synerx 49 Sepracor insomnia 49 liprotamase 49 ZEGERID Chewable Tablets 49 initiate multicenter 49 Alair System 49 synthetic lipoglycopeptide antibiotic 49 Inc XNPT 49 PrevOnco ™ 49 Nebido 49 testosterone gel LibiGel 49 ALN VSP Phase 49 Vibativ 49 ACCLAIM II 49 indiplon capsules 49 LO LOESTRIN FE 49 HPV vaccine GlaxoSmithKline Cervarix 49 INTUNIV TM guanfacine extended 49 successfully commercialize Silenor 49 Exenatide LAR 49 Orphan Drug designations 49 confirmatory pivotal 49 Recommends Approval 49 Contrave NDA 49 vinorelbine emulsion 49 Fast Track Status 49 follicular Non Hodgkin 49 GLP toxicology studies 49 exploratory Phase IIa 49 GTC recombinant form 49 Kynapid 49 budesonide MMX Phase III 49 Vaxfectin TM formulated 49 HepeX B 49 ANDA abbreviated 49 MethyPatch 49 Adventrx 49 Onrigin 49 Orphan designation 49 Euronext Brussels ABLX 49 R sipuleucel T 49 Impax generic 49 IND Investigational New 48 Urocidin 48 Phase III ADT 48 NASDAQ GNTA 48 compound CIP FENOFIBRATE 48 Vaxfectin formulated 48 vivo toxicology 48 Viviant 48 Monovisc 48 generic Lovenox 48 Fast Track designations 48 Solzira 48 HuCAL antibodies 48 IND submission 48 Zemplar Capsules 48 Application MAA 48 im peramivir 48 BEMA TM Fentanyl 48 Prosaptide 48 PMA submission 48 synDNA TM 48 Corlux 48 recombinant PSMA vaccine 48 Eliquis 48 submit Biologics License 48 Miikana 48 Afresa 48 Biologic License Application 48 ChronVac C 48 KYNAPID 48 Gestiva 48 Acthar repository corticotropin injection 48 Rasilez HCT 47 RIGScan CR 47 tolevamer 47 Intermezzo ® NDA 47 Hitachi Fujifilm 47 Ventrus 47 Zolpidem Tartrate Tablets 47 Centralized Procedure 47 initiate Phase IIb 47 APF# NDA 47 EDQM 47 NeuVax 47 rhThrombin 47 IV RSD# 47 OraTest 47 USFDA approval 47 hoFH 47 Marketing Authorization Applications 47 HPV vaccine Cervarix 47 SURFAXIN 47 Thalidomide Pharmion 47 Application BLA 47 Merck Arcoxia 47 naronapride 47 Increlex TM 47 Sertraline Hydrochloride Tablets 47 Marketing Authorization Application 47 LibiGel NDA 47 Phase lll 47 Brilique 47 XIAPEX 47 Approvable letter 47 Uplyso 47 Novartis AG Galvus 47 Arranon 47 sNDA submission 47 molecular imaging radiopharmaceuticals 47 CHMP recommendation 47 cytokine immunomodulator 47 Rhucin ® 47 market PolyHeme commercially 46 novel therapeutic antibodies 46 IDE Investigational Device Exemption 46 Market Approval PMA 46 sBLA 46 Plenaxis R 46 OncoVex 46 Melody Transcatheter Pulmonary Valve 46 Accelerated Assessment 46 supplemental Biologics License Application 46 Inc CRIS 46 Aloxi Injection 46 Alimta pemetrexed 46 Biophan patent 46 Meloxicam Tablets 46 antibiotic telavancin 46 Technosphere Insulin System 46 HeartWare System 46 Liposomal Grb 2 46 IGXT IntelGenx today 46 Esbriet ® 46 Conditional Approval 46 Australian Therapeutic Goods 46 Rhucin R 46 OncoVEX 46 Orphan Designation 46 Junovan 46 Kaletra tablet 46 Teflaro 46 Loramyc ™ 46 k Premarket Notification 46 Encysive Pharmaceuticals Nasdaq ENCY 46 Lorqess 46 Tentative Approval 46 pivotal bioequivalence 46 India DCGI 46 intranasal ketamine 46 MyVax personalized immunotherapy 46 Orphan Drug Status 46 vitro dissolution 46 investigator Donna Tartaglino 46 drug tesmilifene 46 OMS#HP 46 Cetirizine Hydrochloride Syrup 46 Avoid jalapenos 46 Doribax 45 Biologics License Applications 45 FDA approvable letter 45 Mylan ANDA 45 Phase 1a clinical 45 RSR# 45 FluINsure 45 Oilsands Quest announces 45 FIRMAGON R 45 Investigational Device Exemption 45 generic enoxaparin sodium 45 pill Galvus 45 brentuximab 45 Fluviral 45 Drug Application 45 biosimilar filgrastim 45 USFDA nod 45 Optaflu 45 Elonva 45 Firazyr 45 EXPLORE Xa 45 Phase Ib study 45 PROMUS Element Stent System 45 Vimovo 45 QAB# indacaterol 45 Egrifta 45 lorcaserin NDA 45 OMP designation 45 Provenge prostate cancer 45 HCV antiviral 45 Approvable 45 Preos 45 Paragraph IV certifications 45 Nasdaq OPTR 45 Glaxo Cervarix 45 Pennsaid Plus 45 requiring Asthmatx 45 NerPharMa 45 Multiplied Media announces 44 Visian Toric ICL 44 Cinquil 44 Eucreas 44 Expedited Review 44 Exploratory IND 44 Xcellerated T Cells 44 BrachySil 44 transfusional iron overload 44 NASDAQ NVAX 44 FIRAZYR 44 Trofex 44 APEX PD 44 Omapro 44 Raf kinase inhibitor 44 molecular imaging pharmaceuticals 44 Aryx 44 CMDCAS 44 subsidiary Glenmark Generics 44 OraTest R 44 CLIRS 44 QTinno TM 44 Biologics License Application 44 IND CTA 44 Clinical Trial Application 44 Market Authorization Application 44 AMPAKINE CX# 44 SAR# [004] 44 ENRICH trial 44 targeted molecular radiotherapeutics 44 Solorel 44 bafetinib demonstrated 44 eprodisate KIACTA TM 44 WHO prequalification 44 PEARL SC 43 Preliminary Approval 43 OrCel R 43 Novartis Gilenia 43 Taxol r 43 Phase #b/#a 43 Vicor anticipates 43 Orosi Mill project 43 REGEN trial 43 symbol OCE 43 APEX AMI 43 bioFILM PA TM 43 molecular radiotherapeutics 43 blood thinner prasugrel 43 lorcaserin Phase 43 ie antibody mediated 43 MyVax 43 Marketing Authorization 43 Evoltra TM 43 XENAZINE 43 Orthopedic Advisory Panel 43 eCTD format 43 ADDERALL XR R 43 LSE PFZ 43 pertussis Tdap vaccine 43 BLA resubmission 43 Harry Palmin President 43 adrenergic regulation 43 OLpur TM H2H 43 DepoMed 43 NDA resubmission 43 thorough QT 43 PMA Supplement 43 CLIA Waiver 43 Intravail R 43 Certican 43 phase IIa 43 PRECISE trial 43 Fast Track Designation 43 Orphan Drug designation 43 OncoGenex Technologies 43 Hedgehog antagonist 43 NDA BLA 43 IIb clinical trial 43 rALLy trial 43 eg NDA BLA 43 Rocmec Closes 43 PRECISE Trial 43 Orphan Drug status 43 WILEX 43 Nimotuzumab anti 43 sporicidal product 43 vernakalant IV 42 Marketing Authorisation 42 CLIA waiver 42 adjuvant GIST 42 BC SeraPro 42 Alnylam #x# 42 Orexigen Contrave 42 telavancin NDA 42 Silenor NDA 42 FDA Antiviral Drugs 42 TRAIL receptor antibody mapatumumab 42 received CE Conformite 42 viii inability 42 Lambert Eaton Myasthenic 42 lender consents 42 mertansine 42 develop GED aPC 42 Ranbaxy Laboratories Ltd. #.BY 42 Triage Stroke Panel 42 Japanese MHLW 42 midstage clinical trial 42 Q4 CY# 42 Oncogenex 42 Pfizer maraviroc 42 lesinurad 42 phase Ib 42 Accelerated Approval 42 PS# DARA 42 orally bioavailable compound 42 Investigational Medicinal Product 42 approvable letters 42 drug belatacept 42 exemption IDE 42 Decentralized Procedure DCP 42 preclinical pharmacokinetic 42 sBLA filings 42 Arzerra ofatumumab 42 European Medicines Evaluation 42 ThyroTest R 42 subcutaneous ORENCIA 42 BNC# 42 PRICES REALIZED Free 42 CVac 42 Fampyra 42 GALNS 42 DC Bead 42 Dextofisopam 42 infant formula contaminant 42 MVA MUC1 IL2 42 #k PMA sNDA 41 Scientific Advice 41 unpartnered guanosine nucleotide analog 41 premarketing 41 Commences Initial 41 cSSTI 41 generic Lipitor 41 orphan designation 41 Phase III TRIST 41 Verigene System 41 Panacos Pharmaceuticals 41 Dossier IMPD 41 Eszopiclone tablets 41 postherpetic neuralgia PHN painful 41 Phase IIb III 41 Mutual Recognition Procedure 41 Biologics Licensing 41 Humanitarian Device Exemption 41 Therapeutic Goods Administration TGA 41 MHLW 41 initiate Phase Ib 41 ANDA filer 41 Estorra 41 TSX VENTURE SPH.H 41 Hyperthermia System 41 SFDA approval 41 Company Skouries Olympias 41 Regulatory Approval 41 Amyvid 41 Levadex 41 AppSpace.com 41 Regulate Tobacco 41 symbol FGT 41 BioCancell 41 Esbriet 41 EGRIFTA ™ 41 Medicinal Products EMEA 41 Adenuric 41 PSMA ADC 41 CytoFabTM 41 daily Glumetza TM 41 commercialize Qutenza 41 securityholder approvals 41 Toric ICL 41 Company LUMA imaging 40 Recoverable PGM ounces 40 Epitan 40 PhG alpha 1 40 Confirmatory testing 40 stockholder approvals 40 regulatory approval 40 AFSSAPS 40 Approvable Letter 40 COSIRA trial 40 Thorough QT 40 Promus Element stent 40 TKM Ebola 40 Dr. Rafel Rieves 40 StaphVax 40 PRESEPT study 40 Targacept TRGT 40 Oncotype DX colon cancer 40 suburban St.Louis 40 Obtains Regulatory 40 GMP Certification 40 trading symbol GCKO 40 spokeswoman Lenore Gelb 40 gave Makena orphan 40 An ArteFill Skin 40 requisite stockholder 40 Priority Review 40 human antithrombin 40 Zerenex Phase 40 Lilly Effient 40 generic atorvastatin 40 Shonin approval 40 Albany Molecular AMRI 40 illumigene 40 Albuferon Phase 40 dexanabinol 40 partner Lux Biosciences 40 ZURICH AFX Novartis AG 40 adjuvant cisplatin 40 Generac Holdings 40 GRAS notification 40 PINKSHEETS PHMB 40 Final Approval 40 paliperidone palmitate 40 subcutaneous PRO 39 blood thinner rivaroxaban 39 EvaMist NDA submission 39 ORBIT II 39 use authorization EUA 39 rheumatoid arthritis Orencia 39 ® escitalopram oxalate 39 Clolar 39 Reloxin R 39 Aaron Conetta 39 PROLACRIA ™ 39 REVIVE TA 39 COMBIDEX 39 Biglow Canyon 39 generic Ovcon 39 granted orphan medicinal 39 CytoFab ™ 39 Directorate TPD 39 daily bactericidal antibiotic 39 BENLYSTA 39 targeting refractory relapsing 39 commercialize oritavancin 39 Primera Bioscience 39 Zevtera 39 Conformite Europeene 39 rituximab Rituxan R 39 Promacta 39 JPI JJB 39 modified REGENESIS Phase IIb 39 Oncotype 39 randomized controlled multicenter 39 Firdapse ™ amifampridine phosphate 39 Zenotech Laboratories Ltd 39 drug Mylotarg 39 initiate Phase 1b 39 HCA refiles 39 Selling Securityholder 39 confirmatory Phase 3 39 Dainippon Sumitomo 39 FDA Psychopharmacologic Drugs 39 TASKi3 39 rotary VAD 39 Fusilev 39 Swissmedic 39 NASDAQ SGEN 39 mutually satisfactory definitive 39 almorexant 39 Sipex stockholders 39 Atryn 39 Provecta 39 metallurgical flowsheet 39 MTWA Module 39 HSR clearance 39 MVax 39 Dennis Podlesak 38 Fampridine SR Acorda Therapeutics 38 Therapeutic Products 38 Miikana Therapeutics 38 alogliptin NDA 38 thecompletion 38 Aveo Pharmaceuticals 38 preliminary cyanide amenability 38 Megapharm Ltd. 38 MIVI TRUST 38 developing calcitonin 38 No Objection Letter 38 SynX 38 Dendreon Provenge 38 Exelbine NDA 38 Domilens 38 pediatric exclusivity 38 caustic fusion diamond 38 spokesman Ning Shuyong 38 PureGraft 38 REN Property 38 User Fee Act 38 dose escalation phase 38 Guidant stent 38 Phase IIa proof 38 Orphan Drug Designation 38 repopulate CNS 38 iNews Aggregator 38 resubmits 38 FDA Accelerated Approval 38 Generex Biotechnology GNBT 38 DAC HYP 38 self affirmed GRAS 38 LymphoStat B Phase 38 Inc NASDAQ CISG 38 AppTec acquisition 38 biogeneric drugs 38 EMPOWER Study 38 Montaur 38 Yahoo capitulates 38 rabies immune globulin 38 BC EAO 38 Subpart H 38 equivocal appendicitis 38 taliglucerase alfa 38 Huaiyin Power Plant 38 Sturgeon Upgrader 38 traunch 38 ReN# stem cell 38 Investors reacted cautiously 38 CryoSeal FS System 38 Administration TGA 38 Conformite Europeenne CE 37 PRIMO CABG 37 aesthetic dermal fillers 37 CHMP opinion 37 Prexige painkiller 37 Combined License Application 37 Medidur FA 37 randomized Phase 2b 37 Phase IIIB IV 37 requisite regulatory approvals 37 Menaflex implant 37 NYSE VSI 37 MediWound 37 chronic peripheral neuropathic 37 conditionally approves 37 approve Arcoxia 37 GMP certification 37 TSX VENTURE SVT Savant 37 Marketing Authorizations 37 asthma immunotherapeutic 37 ReCell 37 Lumera stockholders 37 SYMMETRY trial 37 Genome Diagnostics 37 AAMAC warrantholders 37 resubmission 37 Healive 37 AsepticSure 37 NASDAQ ITMN 37 TSX OZN AMEX OZN 37 License Application 37 MVLWB 37 hepatitis B vaccine Heplisav 37 Company OTCBB LITS 37 dose cohort 37 CUSF application 37 APEX AMI trial 37 Welfare MHLW 37 cervical cancer vaccine Cervarix 37 regardingthe 37 Securite Sanitaire des Produits 36 Cerepro 36 include ruggedized LCOS 36 novel MAbs 36 ICON7 36 IMPELLA R 36 Agilent E#C 36 resultsof 36 Subpart E 36 Qinnan Production Sharing Contract 36 ANVISA 36 PEP# [001] 36 Cologuard 36 Drug Administration USFDA 36 regulatory approvals 36 Windows Installer XML WiX 36 Phase 2a proof 36 ACCEDE 36 Itibiti Systems 36 NeutroTest TM 36 upon Trevali metallurgical 36 Manulife Brompton Advantaged Bond 36 manufactures fluorescent lighting 36 Accelerated Feasibility Study 36 dose escalation clinical 36 EDSP 35 MUMBAI Glenmark Pharmaceuticals 35 dose titration 35 noninvasive prenatal 35 Antitrust Improvement 35 NYSE Amex GORO 35 BBI# 35 Rincon Lithium 35 Fast Track designation 35 Transgene therapeutic 35 Shire velaglucerase alfa 35 Gemini OTCBB GXPI 35 RECEPTORS LLC 35 ANDAs abbreviated 35 Qualified Institutional Buyers QIB 35 TSX VENTURE AXM 35 y Ambiente SERNA Honduras 35 phase halite blanks 35 Glenmark Generics Ltd 35 JSE GBG 35 GBP JPY Classical 35 IIIA NSCLC 35 Bioresearch Monitoring 35 II SBIR 35 GENASIS clinical 35 Buckreef Gold 35 Ultimate Squeegee 35 TakeTwo Interactive 35 Severe infusion 35 LUMINATE 35 ImmunoVEX HSV2 35 offers flavorful wholesome 35 Belo Blato wind 35 Offering Circulars 35 insiders recused 35 Council Zoning Neighborhoods 35 mineralogical studies 35 Shareholder Approval 35 EPA ToxCast 35 Rev. Spiver Gordon 35 horizontal Haynesville shale 35 inhaled insulin Afrezza 35 PROPEL trial 35 SiBiono 35 Bayesian statistical 35 FORTIS M trial 35 blood thinner Lovenox 35 CardioMag 35 Liu Xiaofeng 35 Intraday Support 34 pixantrone NDA 34 validation 34 POWERSTACK tm MC# 34 draft SEIS 34 geological mapping trenching 34 Ditem 34 bioFILM PA ™ 34 constitutional amendment disallowing 34 Pending regulatory approvals 34 CallWave stockholders 34 Proxy Forms 34 consents authorizations 34 promote ceftobiprole 34 Jaypee Infra 34 vaccine Cervarix 34 Principle AIP 34 Preliminary plat 34 Zippi Swap 34 undertake confirmatory 34 CUSF 34 Neose subsequent 34 Catalyst Semiconductor stockholders 34 Lockerby Depth 34 submittal 34 Raja Azmi submitted 34 Carticept 34 China Phytase corn 34 KCM HOLDINGS CORP. 34 Approval 34 SLUP 34 Minera Andes announces 34 Sherridon Property 34 von Eschenbach nomination 34 cortical stimulation 34 TSX VENTURE PTU 34 TSX VENTURE EXN 34 F.D.A. 33 Nyngan Scandium Project 33 Veeco Labs 33 ComfortScan system 33 Borosi concessions 33 Corporation VOLC 33 Zemiva 33 remitting Multiple Sclerosis 33 exclusivity periods 33 Campaigns uncork 33 NYSE Amex TGB Taseko 33 WDEQ Permit 33 hematological indications 33 NuroPro ® diagnostic 33 ISO Certification 33 Arehada China 33 Insiders subscribed 33 Company OTCBB SNEY 33 Wapiti Montney 33 scoping prefeasibility 33 MBB Industries AG 33 follow ons PIPEs 33 FRANKFURT P7Z 33 Microcutter 33 Cypress Sharpridge 33 PillCam Colon 33 COY7m@aol.com 33 Generally Tamarkin 33 Liwan #-#-# 33 Hanlong transaction 33 astonishing Siemionow 33 Hartnell acrobatic 33 carbohydrate polymers 33 Environmental Impact Review 33 OGE Enogex Partners LP 33 CE Marking 33 Judge Gregg Zive 33 Commission BCUC 33 Google Permissions 33 prosecutor Matt Kemmy 33 cementing Pathway 33 SIDEX Limited Partnership 33 Disinterested shareholders 33 DATES Comments 33 Honda Asanuma 33 Onglyza metformin combo 33 symbol TTPY 33 Gastrointestinal Drugs Advisory 33 approval 33 Zymafos 33 MagPotash 32 JunJing II 32 TSX VENTURE MCK 32 Mandatory Convertible Bonds 32 CoPP 32 Eligard prostate cancer 32 #.# Intraday Resistance 32 SVEC Constructions 32 disinterested shareholder 32 CV Therapeutics stockholders 32 soreness subsides 32 clearance eg probenecid 32 Synsorb 32 Previstage TM GCC 32 generic biologic 32 ISO TS #:# certification 32 cethromycin NDA 32 Oncotype Dx 32 began distributing Levothroid 32 SuperStitch ® 32 PROLACRIA 32 blood thinner Exanta 32 Dzheitune 32 KwaZulu Natal Gambling 32 SmartWave platform 32 Test PSAT NMSQT 32 AquaBounty submitted 32 Thinksoft Global 32 NAOSC 32 Secretaria de Recursos Naturales 32 oceanwide tsunami 32 technology subsidiary TradeStation 32 ACAM# smallpox vaccine 32 RedChip Visibility Program 32 underwritten dividend reinvestment 32 orphan drug 32 Zanaflex Capsules competition 32 Med Biogene 32 secondary generalization 32 resolicitation 32 Inamed silicone implants 32 Environmental Compatibility 32 CR CRu 32 Participation Payment Deadline 32 ZMTP 32 substitutional listing 32 Scopus Affiliation Identifier 32 application 32 deducting placement 32 Geotextile tubes 32 high-k/metal-gate 32 resource delineation 32 Ceplene/IL-2 32 PTCRB certification 31 ValuEngine Rating 31 Bella Vita Clinic 31 exciting Rainer Klement 31 flotation testwork 31 Escalones 31 AVADO 31 Avastin adjuvant 31 SenoRx Nasdaq SENO 31 Formal Dispute Resolution 31 securityholder approval 31 precincts reporting Landrieu 31 OX2 engine 31 REC FPO 31 Concurrence motion 31 Te Rere Hau 31 Nadcap accreditation 31 VScan test 31 Juvista 31 spokesman Gene Fadness 31 bigpharma dealmaking 31 seat belt pretensioner 31 Avantome 31 Pembina Cardium horizontal 31 Libby adit 31 regulatory authorizations 31 symbol THI 31 conditional inter alia 31 reapproval 31 GRAS determination 31 PCA Directive 31 Yellowjacket JV 31 PDEIS 31 chairman Tony Frankham 31 information rfi requests 31 SSRI antidepressant indicated 31 GoDaddy.com SSL Certificates 31 underwriting discounts commissions 31 METAspectrum evaluation provides 31 Nevada PUCN 31 testwork carried 31 Currently CitySide Tickets 31 minister Kadoura Fares 31 deducting underwriting 31 MONTROSE Montrose Family 31 customary regulatory approvals 31 RFI RFP 31 Concept POC 31 GRAS status 31 eMax Worldwide 31 heap leach amenability 31 ReneSola Ltd. 31 Whitewash Waiver 31 USX Selection Committee 31 PGR Paragon 31 Minotaur IV launch 31 Orbit Validation IOV 31 ADC2 31 QFII license 30 regulatory clearances 30 Turenne Investissement 30 PSF guaranty 30 postmarket studies 30 Andacollo transaction 30 governmental approvals 30 Industrial Siting Council 30 INR# INR# 30 Environment Impact Statement 30 Dendreon prostate cancer 30 antitrust clearance 30 Soledad Dipolos 30 Land Use Permit 30 additional cytogenetic abnormalities 30 UIC Permit 30 Dussafu PSC 30 Marketing Authorisations 30 governor Hamdullah Danishi 30 Nanjinzhao 30 nonsampling errors 30 Kang Seung ju 30 trans urethral resection 30 CE Conformité Européenne 30 convertible debenture financing 30 TSX VENTURE OGR 30 prefeasibility feasibility 30 MUST BE TYPED 30 Excellent Accreditation status 30 Roger Pafford 30 Adolf Hitler dictatorial 30 missy fit 30 Bookbuilding 30 Guilin Sanjin Pharmaceutical 30 Entitlement Issue 30 KEDFA 30 drilling coring 30 approvals 30 prospecting geological mapping 30 Lawmakers overrode 30 d2p